- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06723847
Navigating the Learning Curve of Robotic Pancreatoduodenectomy: Feasibility, Proficiency, and Mastery in a First-generation Surgeon (LC-RPD)
December 4, 2024 updated by: Niccolò Napoli, University of Pisa
This study delineates the learning curve of robotic pancreatoduodenectomy (RPD) for first-generation surgeons, using the Comprehensive Complication Index (CCI) to assess patient outcomes and the PD-ROBOSCORE to stratify patients for their risk to develop post-operative complications.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to define the learning curve of a first-generation surgeon who implemented robotic pancreatoduodenectomy.
When compared to previous studies on the same issue, the current study has several distinctive features.
Firstly, the learning curve was defined using the cumulative sum method, with the comprehensive complication index as the main outcome metric.
The comprehensive complication index provides a holistic view of the burden of postoperative complications in each individual patient, correlating with key outcome measures such as length of hospital stay, use of hospital resources, and ultimately mortality.
Secondly, outcomes were adjusted by procedure complexity based on the newly described PD-ROBOSCORE (Surgery.
2023;173:1438-1446).
This is the first study assessing the learning curve of robotic pancreatoduodenectomy while incorporating difficulty levels.
Study Type
Observational
Enrollment (Actual)
313
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
All patient underwent robotic pancreaticoduodenectomy at our institution regardless for the pathology
Description
Inclusion Criteria:
All patients underwent robotic pancreaticoduodenectomy.
Exclusion Criteria:
None.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient underwent robotic pancreaticoduodenectomy
All patients undergoing robotic pancreaticoduodenectomy regardless of the pathology for which they underwent it
|
All procedures are performed used a standard technique of our center for robotic pancreaticoduodenectomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative complications
Time Frame: 90 days
|
90-day post-operative complications assessed by the Comprehensive Complication Index (CCI)
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2008
Primary Completion (Actual)
October 1, 2023
Study Completion (Actual)
June 1, 2024
Study Registration Dates
First Submitted
December 4, 2024
First Submitted That Met QC Criteria
December 4, 2024
First Posted (Estimated)
December 9, 2024
Study Record Updates
Last Update Posted (Estimated)
December 9, 2024
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- LC-RPD-Boggi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
They will be shared upon request
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Robotic Pancreaticoduodenectomy
-
Peking Union Medical College HospitalCompleted
-
Thomas Jefferson UniversityUnknownPancreaticoduodenectomyUnited States
-
Xinrui Zhu,MDNot yet recruitingLaparoscopic Pancreaticoduodenectomy
-
Peking Union Medical College HospitalPeking University First Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaboratorsCompletedDrainage | PancreaticoduodenectomyChina
-
Mayo ClinicTerminatedPancreaticoduodenectomyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedPancreaticoduodenectomyUnited States
-
Mansoura UniversityCompletedPancreaticoduodenectomy
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Chen XiaopingUnknownPancreaticoduodenectomyChina
Clinical Trials on Robotic pancreaticoduodenectomy
-
Ruijin HospitalIntuitive SurgicalCompletedPancreatic Adenocarcinoma | Chronic Pancreatitis | Ampullary Adenocarcinoma | Cholangiocarcinoma, Extrahepatic | Pancreatic Cysts | Pancreatic Endocrine Tumors | Duodenal AdenocarcinomaChina
-
Peking Union Medical College HospitalRecruitingPancreatic NeoplasmChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedPancreaticoduodenectomyUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingPancreatic Cancer Resectable
-
Tongji HospitalShanxi Province Cancer Hospital; Fudan University; Qilu Hospital of Shandong... and other collaboratorsEnrolling by invitationPeriampullary AdenocarcinomaChina
-
Tongji HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Peking Union... and other collaboratorsUnknownSurgery | Periampullary Cancer | Pancreatic Ductal AdenocarcinomaChina
-
Minia UniversityRecruitingPancreatic Ductal Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Distal Cholangiocarcinoma | Ampullary Carcinoma | Duodenal AdenocarcinomaEgypt
-
The First Affiliated Hospital of University of...Not yet recruitingPancreatic Cancer | Common Bile Duct Diseases | Periampullary Carcinoma
-
Peking Union Medical College HospitalRecruitingThe Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer (MIOPP)Surgery | Pancreatic CarcinomaChina
-
Duke UniversityCompletedPancreatic Disease